Skip to main content
PLIANT THERAPEUTICS, INC. logo

PLIANT THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · PLRX ISIN · US7291391057 LEI · 5493002Q5LITR7VHZH02 US Professional, scientific and technical activities
Open in API
Filings indexed 403 across all filing types
Latest filing 2020-06-03 Director's Dealing
Country US United States of America
Listing US PLRX

About PLIANT THERAPEUTICS, INC.

https://pliantrx.com/

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of fibrosis and related diseases. The company leverages its expertise in integrin biology to create tissue-specific treatments. Its therapeutic approach centers on modulating integrin activity and inhibiting TGF-β1 signaling, which are key molecular drivers of fibrosis. Pliant utilizes its proprietary discovery platform to advance a pipeline of integrin-based product candidates, aiming to provide safer and more effective therapies for patients.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2020-06-03 English
S-1/A
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 2 to Form S-1 Registration Statement filed with the SEC, dated June 2, 2020, for Pliant Therapeutics, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings (IPOs) or other securities offerings. The text includes details about the offering, underwriting, risk factors, business overview, management, financial data, and other disclosures typical of an S-1 filing. This is not an annual report, earnings release, or any other financial report type. It is a capital markets filing related to the registration of securities for public sale. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). An S-1 registration statement amendment is a capital/financing update document. Therefore, the appropriate classification is CAP with high confidence.
2020-06-02 English
Regulatory Filings 2020
Regulatory Filings
2020-06-01 English
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It is not a financial report, earnings release, or management discussion. The document primarily serves as a regulatory filing to register securities for trading on an exchange (Nasdaq). It contains no financial statements or detailed financial data. The document length is 3222 characters, which is relatively short and consistent with a regulatory filing rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-05-29 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC regarding a Registration Statement on Form S-1, specifically a request for acceleration of effectiveness of the Registration Statement. It mentions distribution of a Preliminary Prospectus and compliance with securities regulations by underwriters. The content is a correspondence related to the registration and offering process, not the actual registration statement or prospectus itself. The document length is short (1836 characters) and it is a formal communication rather than a financial report or detailed filing. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and correspondence that do not fit other categories.
2020-05-29 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-1. It is a formal communication related to the registration process of securities, specifically requesting the SEC to declare the registration statement effective earlier than originally planned. The document does not contain financial statements, management discussion, or detailed financial data. It is a regulatory communication related to capital markets activity but is not itself a financial report or earnings release. Given the nature of the document as a formal regulatory communication and request, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2020-05-29 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.